Clinical Trials Logo

Clinical Trial Summary

An intraperitoneal implanted catheter is always necessary to perform Peritoneal Dialysis. Catheter insertion has been associated with infectious complication such as Exit Site Infection (ESI), Tunnel Infection and Peritonitis. The last one may lead to loss of the technique because the need of catheter removal. Most of international guidelines recommends the use of prophylactic antibiotics. Different protocols has been used, mostly intravenous single injection before the procedure. For the last 25 years our unit gives a single intraperitoneal dose of Cefazolin immediately after the catheter insertion. The aim of this study is compare the effect of a pre- operative IV dose os Cefazolin with a post- procedure intraperitoneal single dose administration of the same drug.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03046511
Study type Interventional
Source Carmel Medical Center
Contact Victor Frajewicki, MD
Phone 972-4-8250491
Email vfraje@clalit.org.il
Status Recruiting
Phase Phase 3
Start date March 8, 2017
Completion date December 31, 2023

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04034628 - Improving the Outcomes of Peritoneal Dialysis (PD) Catheter Insertion
Completed NCT03569410 - The Effect of Natural Protein vs. Protein Supplements on Peritoneal Dialysis Patients N/A
Completed NCT04302649 - Dialysate Temperature in Peritoneal Dialysis Phase 4
Enrolling by invitation NCT05250752 - Reduction of Peritoneal Glucose Uptake With Use of SGLT2 in Humans Undergoing Peritoneal Dialysis Treatment Phase 2
Recruiting NCT03563898 - Feasibility and Safety in the Management of Fluid Overload in Peritoneal Dialysis Patients Through Sweat Stimulation With the Use of Portable Sauna Bath, Pilot Study N/A
Not yet recruiting NCT05224466 - Characteristics and Clinical Outcomes of Peritoneal Dialysis Patients
Completed NCT03458819 - EMT in Peritoneal Dialysis Patients
Not yet recruiting NCT06045858 - Safety and Efficacy of Apixaban Versus Warfarin in Peritoneal Dialysis Patients With Non Valvular Atrial Fibrillation Phase 2/Phase 3
Active, not recruiting NCT04034966 - Utility of Telemedicine in the Follow-Up of Patients in Peritoneal Dialysis N/A
Completed NCT04923295 - The Effect of Dapagliflozin on Ultrafiltration Among Peritoneal Dialysis Patients N/A
Recruiting NCT03148002 - Peritoneal Dialysis Pilot Study: Evaluating Polyethylene Glycol (PEG) for Constipation Phase 4
Recruiting NCT04572724 - The Effect of Sacubitril/Valsartan on Cardiovascular Events in Dialysis Patients and Efficacy Prediction of Baseline LVEF Value Phase 4
Completed NCT05797181 - The Effect Of Medical Nutritional Therapy On Patients With Sarcopenic Obesity Receiving Peritoneal Dialysis Treatment N/A
Recruiting NCT01893710 - International (Pediatric) Peritoneal Biobank
Completed NCT03382444 - The Kidney and The Brain Study - Assessment of Cognitive Impairment in Advanced CKD
Not yet recruiting NCT05715814 - meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis Phase 3
Completed NCT04046263 - Effect of Velphoro on Serum Phosphate and Albumin in Peritoneal Dialysis Patients Phase 4
Completed NCT03759002 - Association of Mean Platelet Volume and Cardiovascular Disease in Children With End Stage Renal Disease.
Completed NCT04176627 - Assessing Fluid Status of Peritoneal Dialysis Patients With Assistance of Lung Ultrasound
Recruiting NCT04102527 - Evaluation of the Impact of Transit Troubles in Patients Undergoing Peritoneal Dialysis